The analysis of Nrp-1 expression has indeed revealed that Nrp-1-negative bona fide pTreg cells were significantly enriched at tumor site compared to spleen, ranging around 40–90% of total tumor-infiltrating Treg depending on the tumor type (61). This evidence concerns the gene NRP1 and neoplasm.